Jul 17, 2023 | 2023, Investors, Press Releases
More detailsJul 10, 2023 | 2023, Investors, Press Releases
More detailsJul 4, 2023 | 2023, Press Releases, Scientific
The study was conducted by scientists at Philochem AG, the wholly owned Swiss subsidiary company of the Philogen group. The paper can be accessed on the Nature Chemistry website at the following link. Nat_chem_280223_press_releaseJul 3, 2023 | 2023, Investors, Press Releases
More detailsJun 28, 2023 | 2023, Press Releases
Philogen S.p.A today announced that it has entered into a Service and Supply Agreement with IBSA (Institut Biochimique SA) to produce a recombinant therapeutic protein at Philogen GMP Facilities in Siena (Italy). Press_Release_IBSA_PhilogenJun 26, 2023 | 2023, Investors, Press Releases
More details
Recent Comments